Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (531-540 of 927) with videos related to

Pageof 93
Sort By:
Journal of the American College of Cardiology|March 5, 2004
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapyGreetje J de Grooth, Kim E Zerba, Shu-Pang Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2024
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
The American Journal of Cardiology|November 13, 2024
Sex Differences in a Real-World Registry Examining Coronary Lithotripsy for Calcified LesionsMartijn J H van Oort, Federico Oliveri, Al Amri Ibtihal, et al.
Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.
The American Journal of Cardiology|June 21, 2011
Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasoundJoëlla E van Velzen, Fleur R de Graaf, J Wouter Jukema, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 20, 2011
Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysisJoëlla E van Velzen, Fleur R de Graaf, Michiel A de Graaf, et al.
Journal of the American College of Cardiology|June 5, 2007
Usefulness of 64-slice multislice computed tomography coronary angiography to assess in-stent restenosisFilippo Cademartiri, Joanne D Schuijf, Francesca Pugliese, et al.
European Heart Journal|June 3, 2026
Safety of low lipoprotein(a) levels: the FOURIER trialBaris Gencer, Robert P Giugliano, Xinhui Ran, et al.
The American Journal of Cardiology|December 28, 2016
Prevalence by Computed Tomographic Angiography of Coronary Plaques in South Asian and White Patients With Type 2 Diabetes Mellitus at Low and High Risk Using Four Cardiovascular Risk Scores (UKPDS, FRS, ASCVD, and JBS3)Sanjay N Gobardhan, Aukelien C Dimitriu-Leen, Alexander R van Rosendael, et al.
Atherosclerosis|February 3, 2017
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increaseBranko Simic, Pavani Mocharla, Margot Crucet, et al.
Pageof 93

Showing results (531-540 of 927) with videos related to

Sort By:
Pageof 93
Journal of the American College of Cardiology|March 5, 2004
The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapyGreetje J de Grooth, Kim E Zerba, Shu-Pang Huang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 24, 2024
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observationShaun G Goodman, Philippe Gabriel Steg, Michael Szarek, et al.
The American Journal of Cardiology|November 13, 2024
Sex Differences in a Real-World Registry Examining Coronary Lithotripsy for Calcified LesionsMartijn J H van Oort, Federico Oliveri, Al Amri Ibtihal, et al.
Pharmacogenomics|September 21, 2016
Rooted in risk: genetic predisposition for low-density lipoprotein cholesterol level associates with diminished low-density lipoprotein cholesterol response to statin treatmentRoelof Aj Smit, Iris Postmus, Stella Trompet, et al.
The American Journal of Cardiology|June 21, 2011
Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasoundJoëlla E van Velzen, Fleur R de Graaf, J Wouter Jukema, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|July 20, 2011
Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysisJoëlla E van Velzen, Fleur R de Graaf, Michiel A de Graaf, et al.
Journal of the American College of Cardiology|June 5, 2007
Usefulness of 64-slice multislice computed tomography coronary angiography to assess in-stent restenosisFilippo Cademartiri, Joanne D Schuijf, Francesca Pugliese, et al.
European Heart Journal|June 3, 2026
Safety of low lipoprotein(a) levels: the FOURIER trialBaris Gencer, Robert P Giugliano, Xinhui Ran, et al.
The American Journal of Cardiology|December 28, 2016
Prevalence by Computed Tomographic Angiography of Coronary Plaques in South Asian and White Patients With Type 2 Diabetes Mellitus at Low and High Risk Using Four Cardiovascular Risk Scores (UKPDS, FRS, ASCVD, and JBS3)Sanjay N Gobardhan, Aukelien C Dimitriu-Leen, Alexander R van Rosendael, et al.
Atherosclerosis|February 3, 2017
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increaseBranko Simic, Pavani Mocharla, Margot Crucet, et al.
Pageof 93